Preview

Medical Immunology (Russia)

Advanced search

INTENSITY OF SPECIFIC SENSITIZATION AND IMMUNE PROFILE IN PATIENTS WITH BRUCELLOSIS

https://doi.org/10.15789/1563-0625-2016-4-365-372

Abstract

The authors propose a new methodological approach to rapid intensity assessment of specific sensitization in acute brucellosis. This technique shows high sensitivity (98%), and specificity (97%). We revealed a direct relation between the intensity of specific IgE-dependent sensitization accompanied by development of immunosuppressive state in patients with brucellosis, i.e., a mean reduction of total CD3+ cell counts by 17.9%; CD3+CD4+ cells, by 13.3%; CD16+CD56+, by 4.4%. Phagocytic ability of blood neutrophils was decreased by 25.8%. The study has shown that an increased reagin-dependent sensitization in brucellosis is closely associated with emergence of severe immunosuppression.

About the Authors

N. S. Sarkisуan
Stavropol Antiplague Institute
Russian Federation

Laboratory Physician, Clinical Research&Prevention Diagnostic Laboratory,

355035, Stavropol, Sovietskaya str., 13-15



D. G. Ponomarenko
Stavropol Antiplague Institute
Russian Federation
PhD (Biology), Head, Laboratory of Brucellosis and Division of Immunology and Pathomorphology for Special Danger Infections


V. O. Logvinenko
Stavropol Antiplague Institute
Russian Federation
PhD (Biology), Senior Research Associate, Head, Division of Immunology and Pathomorphology for Special Danger Infections


E. L. Rakitina
Stavropol Antiplague Institute
Russian Federation
PhD (Medicine), Leading Research Associate, Division of Immunology and Pathomorphology for Special Danger Infections


M. V. Kostyuchenko
Stavropol Antiplague Institute
Russian Federation
Research Associate, Division of Immunology and Pathomorphology for Special Danger Infections


A. N. Kulichenko
Stavropol Antiplague Institute
Russian Federation
PhD, MD (Medicine), Professor, Director


References

1. Вершилова П.А., Чернышова М.И., Князева Э.Н. Патогенез и иммунология бруцеллеза. М.: Медицина, 1974. 272 с. [Vershilova P.A., Chernyshova M.I., Knyazeva E.N. Pathogenesis and immunology of brucellosis]. Moscow: Medicine, 1974. 272 p.

2. ГОСТ Р 53022.3-2008 «Технологии лабораторные клинические». Требования к качеству клинических лабораторных исследований. Часть 3. Правила оценки клинической информативности лабораторных тестов». [GOST R 53022.3-2008 “clinical laboratory Technology”. Requirements for the quality of clinical laboratory studies. Part 3. The rules of evaluation of clinical informative value of laboratory tests». (In Russ.)]

3. Кишкун А.А. Иммунологические исследования и методы диагностики инфекционных заболеваний в клинической практике. М.: Медицинское информационное агентство, 2009. 712 с. [Kishkun A.A. the Immunological research and methods of diagnostics of infectious diseases in clinical practice]. Moscow: Medical information Agency, 2009. 712 p.

4. Кобзарь А.И. Прикладная математическая статистика. М.: Физматлит, 2006. C. 626-628. [Kobzar A.I. Applied mathematical statistics]. Moscow: Fizmatlit, 2006, pp. 626-628.

5. Лямкин Г.И., Пономаренко Д.Г., Худолеев А.А., Вилинская С.В., Зайцев А.А., Куличенко А.Н. Эпидемическая ситуация по бруцеллезу в Российской Федерации и государствах - участниках Содружества Независимых Государств // Инфекционные болезни: новости, мнения, обучение, 2016. № 1. С. 68-74. [Lyamkin G.I., Ponomarenko, D.G., Khudoleev A.A. Vilinskaya S.V., Zaitsev A.A., Kulichenko A.N. Epidemiological situation on brucellosis in the Russian Federation and the States – participants of the Commonwealth of Independent States. Infektsionnye bolezni: novosti, mneniya, obuchenie = Infectious Diseases: News, Opinions, Training, 2016, no. 1, pp. 68-74. (In Russ.)]

6. Патент № 2574207 Российской Федерации, МПК G01N33/48. Способ дифференциации поствакцинного и инфекционного бруцеллёзного процессов по степени повышенной чувствительности организма к бруцеллам в условиях in vitro / Пономаренко Д.Г., Ракитина Е.Л., Логвиненко О.В., Саркисян Н.С., Костюченко М.В., Куличенко А.Н., Лямкин Г.И., Голубь О.Г., Бердникова Т.В.; заявитель и патентообладатель Федеральное казённое учреждение здравоохранения Ставропольский научно-исследовательский противочумный институт Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека, опубл. 10.02.2016. [Patent no. 2574207 of the Russian Federation, IPC G01N33/48. Method postvaccinale differentiation and infectious processes in brucellosis degree of hypersensitivity to Brucella in vitro/ Ponomarenko, D.G., Rakitin, E.L., Logvinenko O.V., Sarkisyan N.S., Kostyuchenko M.V., Kulichenko A.N., Lyamkin G.I., Dove, G.O., Berdnikova T.V.; applicant and patentee Federal state institution of health Stavropol research antiplague Institute of Federal service for supervision of consumer rights protection and human welfare, publ. 10.02.2016. (In Russ.)]

7. Ройт A., Бростофф Дж., Мейл Д. Иммунология: [пер. с англ.]. М.: Мир, 2000. 592 с. [Roit A., Brostoff J., Mail D. Immunology: [Engl. Transl.]. Moscow: Mir, 2000. 592 p.

8. Уханова О. П. Изучение влияния моноклональных антител к IgE на активацию базофилов периферической крови больных сезонным аллергическим ринитом // Аллергология и иммунология, 2010. Т. 11, № 1. С. 54-56. [Ukhanova, O.P. Study of the effect of monoclonal antibodies to IgE on the activation of basophils in the peripheral blood of patients with seasonal allergic rhinitis. Allergologiya i immunologiya = Allergology and Immunology, 2010, Vol. 11, no. 1, pp. 54-56. (In Russ.)]

9. De Weck A.L., Sanz M.L., Gamboa P.M., Jermann J.M., Kowalski M., Medrala W., Sainte-Laudy J., Schneider M.S., Weber J.M., Wolanczyk-Medrala A. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome: a multicenter study. II. Basophil activation by nonsteroidal anti-inflammatory drugs and its impact on pathogenesis. J. Investig. Allergol. Clin. Immunol., 2010, Vol. 20, no. 1, pp. 39-57.

10. Galinska E.M., Zagorski J. Brucellosis in humans – etiology, diagnostics, clinical forms. Ann Agric. Environ. Med., 2013, Vol. 20, no. 2, pp. 233-238.

11. Pignatti P., Patrizia P., Giselda C., Mona-Rita Y., Gianni P., Gianna M. Basophil activation test is food adverse reactions. J. Clin. Transl. Allergy, 2011, no. 2, Suppl. 1, p. 92.

12. Sainte-Laudy J., Vallon C., Guerin J.C. Analysis of membrane expression of the CD63 human basophil activation marker. Applications to allergologic diagnosis. Allerg. Immunol., 1994, Vol. 26, no. 6, pp. 211-214.

13. Sato S., Tackimoto M., Shukuya A., Kurosaka N., Yanagida N., Utsunnomiya T., Iguchi M., Komata T., Imai T., Tomikawa M., Ebisaw M. Basophil activation marker CD203C is useful in the diagnosis of hen`s egg and cow`s milk allergies in children. J. Allergy Immunol., 2010, Vol. 152, no. 1, pp. 54-61.

14. Schroeder J. T. Basophils: emerging roles in the pathogenesis of allergic disease. J. Immunol. Rev., 2011, Vol. 242, no. 1, pp. 144-160.

15. Skendros Р., Boura P. Immunity to brucellosis. J. Rev. Sci. Tech., 2013, Vol. 32, no. 1, pp. 137-147.


Review

For citations:


Sarkisуan N.S., Ponomarenko D.G., Logvinenko V.O., Rakitina E.L., Kostyuchenko M.V., Kulichenko A.N. INTENSITY OF SPECIFIC SENSITIZATION AND IMMUNE PROFILE IN PATIENTS WITH BRUCELLOSIS. Medical Immunology (Russia). 2016;18(4):365-372. (In Russ.) https://doi.org/10.15789/1563-0625-2016-4-365-372

Views: 936


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)